CHANGJIANG PHARMACEUTICAL GROUP CO., LTD.

Changjiang Pharmaceutical Group Co., Ltd.

300391

CNE100001XN8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
3.97 ^CNY	-4.57%		+3.93%	-48.71%

Apr. 09	Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma	MT
Apr. 01	Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps	MT

Wuhu Yuanche Quanli Investment Center (Limited Partnership) completed the acquisition of a 6.44% stake in Kangyue Technology Co., Ltd. from Shenzhen Shengshi Fenghua Enterprise Management Co., Ltd.

December 29, 2021

Wuhu Yuanche Quanli Investment Center (Limited Partnership) signed an agreement to acquire a 6.44% stake in Kangyue Technology Co., Ltd. (SZSE:300391) from Shenzhen Shengshi Fenghua Enterprise Management Co., Ltd. for approximately CNY 340 million on November 29, 2021. Wuhu Yuanche Quanli Investment Center (Limited Partnership) will buy 22,550,000 shares in Kangyue Technology Co., Ltd. at a price of CNY 14.88 per share.

Wuhu Yuanche Quanli Investment Center (Limited Partnership) completed the acquisition of a 6.44% stake in Kangyue Technology Co., Ltd. (SZSE:300391) from Shenzhen Shengshi Fenghua Enterprise Management Co., Ltd. on December 30, 2021.

Latest news about Changjiang Pharmaceutical Group Co., Ltd.

Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma	Apr. 09	MT
Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps	Mar. 31	MT
YiChang HEC ChangJiang Pharmaceutical's Profit Surges in 2023	Mar. 28	MT
Yichang Hec Changjiang Pharmaceutical Expects Up to 2,627% Profit Surge in 2023	Mar. 12	MT
HEC ChangJiang Pharmaceutical Increases Transaction Limits Under 2 Contracts	Nov. 08	MT
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
HEC ChangJiang Pharmaceutical's Insulin Injection Cleared for Market Launch in China	23-09-26	MT
HEC ChangJiang Pharmaceutical Returns to Profit on Surge in Anti-Viral Drug Sales	23-09-01	MT
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
China Greenlights New Drug Application for HEC ChangJiang Pharmaceutical's Hepatitis C Drug	23-08-16	MT
HEC ChangJiang Pharmaceutical Forecasts Surge in H1 Profit; Shares Rise 5%	23-07-27	MT
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd completed the acquisition of 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd.	23-07-24	CI
HEC ChangJiang Pharma Repurchases $400 Million Convertible Bonds Issued to Blackstone	23-07-06	MT
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd signed Share Transfer Agreement to acquire 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd. for CNY 154.14 million.	23-06-14	CI
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Changjiang Pharma Units Sign 359 Million Yuan Contracts	23-04-17	MT
YiChang HEC ChangJiang Pharma to Return to Profitability	23-03-20	MT
YiChang HEC ChangJiang Pharmaceutical Shareholders to Vote on Disposal of 10% Stake in Controlling Shareholder	23-03-10	MT
Kangyue Technology Adopts New Name After Shifting to Pharmaceuticals	23-03-02	MT
Kangyue Technology to Change Company Name	23-02-07	MT
Heilongjiang ZBD Pharmaceutical to Tie Up With Kangyue Technology on Medicine Supplies	22-12-06	MT
Kangyue Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Kangyue Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Kangyue Technology Co., Ltd. Announces Board Appointments	22-06-23	CI

Chart Changjiang Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Changjiang Pharmaceutical Group Co., Ltd.

More charts

Company Profile

Changjiang Pharmaceutical Group Co Ltd, formerly Kangyue Technology Co Ltd, is a China-based company principally engaged in the research and development, production and sales of drugs. The Company is engaged in three businesses. The pharmaceutical business is engaged in traditional Chinese medicine decoction pieces business, medicinal capsule business and pharmaceutical wholesale business. The internal combustion engine parts business is engaged in the research and development, production and sales of turbocharger products. The photovoltaic equipment business is engaged in the research and development, production and sales of photovoltaic equipment such as laminator and stitch welding machine.

Sector

Pharmaceuticals

Calendar

2024-04-29 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHANGJIANG PHARMACEUTICAL GROUP CO., LTD.	-48.71%	192M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals

Changjiang Pharmaceutical Group Co., Ltd.

Equities

300391

CNE100001XN8

Pharmaceuticals

Wuhu Yuanche Quanli Investment Center (Limited Partnership) completed the acquisition of a 6.44% stake in Kangyue Technology Co., Ltd. from Shenzhen Shengshi Fenghua Enterprise Management Co., Ltd.

Latest news about Changjiang Pharmaceutical Group Co., Ltd.

Chart Changjiang Pharmaceutical Group Co., Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Pharmaceuticals